Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: bluejeans who wrote (1966)	7/7/1998 8:31:00 PM
From: BWAC	Respond to of 2553

I saw the story on the news also. It portrayed GENZL's skin culture technlogy to be quite promising and a much needed service. Some important points were made. One being that time is of the essence to severe burn victims lives and that GENZL could grow enough skin in 3 weeks to cover the entire body from one 2 inch square sample of the victims skin. Quite impressive. I did see one problem though. The story prominently identified Genzyme instead of our company Genzyme Tissue Repair. So if this news causes a pop in the stock price I expect Genzyme to benefit while GENZL slumbers until someone puts it all together..